WHO issues alert against Indian-made syrups after 66 children die in Gambia


Donate
ANKARA (AA) – The World Health Organization Wednesday issued a medical product alert for four contaminated medicines detected in Gambia which have been potentially linked with acute kidney injuries and 66 child deaths.
“The four medicines are cough and cold syrups produced by Maiden Pharmaceuticals Limited in India. WHO is conducting further investigation with the company and regulatory authorities in India,” the UN health agency said on Twitter.
The WHO warned that while the contaminated products have so far only been detected in Gambia, they may have been distributed outside of the West African country.
The UN agency urged all countries to identify and remove these products from circulation to hinder further harm to patients.
According to the alert issued by the WHO, the four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup.
“To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products,” the statement said.
POST YOUR COMMENTS
MAORANDCITIES.COM uses both Facebook and Disqus comment systems to make it easier for you to contribute. We encourage all readers to share their views on our articles and blog posts. All comments should be relevant to the topic. By posting, you agree to our Privacy Policy. We are committed to maintaining a lively but civil forum for discussion, so we ask you to avoid personal attacks, name-calling, foul language or other inappropriate behavior. Please keep your comments relevant and respectful. By leaving the ‘Post to Facebook’ box selected – when using Facebook comment system – your comment will be published to your Facebook profile in addition to the space below. If you encounter a comment that is abusive, click the “X” in the upper right corner of the Facebook comment box to report spam or abuse. You can also email us.